Market Access
Is this an Oppenheimer moment for the life sciences industry?
October 29, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
Turning a 10-Year Vision into a 10-Year Plan
October 27, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
From sickness to prevention: the case for population health management
October 3, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials
October 2, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway
The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?
August 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
Single national formulary and community care: a closer look at the 10-Year Health Plan
August 21, 2025 Business Services, Market Access Gateway to Local Adoption, NHS, Visions4Health
Key strategies to foster digital transformation in the NHS
July 30, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy
The quiet crisis: why medicines operations matter more than ever in the ICB era
July 4, 2025 Business Services, Market Access Gateway to Local Adoption, Integrated Care Board, NHS, Primary Care Networks, Visions4Health
Biocon Biologics gains EU approval for bone health therapies
July 4, 2025 Market Access, Medical Communications, Research and Development Biocon Biologics, Committee for Medicinal Products for Human USE, European Commission, Evfraxy, Oncology, Orthopaedics, Osteoporosis, Vevzuo, bone health, osteoporosis, prostate cancer
Unlocking the gateway to ‘precision’ UK market access
June 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
CSL Behring’s therapy for hereditary angioedema receives positive assessment in Germany
June 26, 2025 Market Access, Market Research, Medical Communications, Research and Development, Sales and Marketing CSL Behring, Institute for Quality and Efficiency in Health Care, Rare Diseases, clinical trials, hereditary angioedema, market access
AOTI achieves broad market access in Germany for diabetic foot ulcer therapy
June 23, 2025 Market Access, Medical Communications, Sales and Marketing AOTI, Diabetes, European pharma market, German pharma market, Wound Healing, diabetic foot ulcers, market access, positive recommendation
Treatment for serious eye disease approved in Scotland
June 12, 2025 Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS
May 22, 2025 Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab
Multiple myeloma treatment approved in Japan
May 21, 2025 Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
